Literature DB >> 24444852

Primary and secondary care attendance, anticonvulsant and antidepressant use and psychiatric contact 5-10 years after diagnosis in 188 patients with psychogenic non-epileptic seizures.

Roderick Duncan1, Christopher D Graham2, Maria Oto3, Aline Russell4, Laura McKernan5, Sue Copstick4.   

Abstract

BACKGROUND AND OBJECTIVES: There have been few studies of long-term outcome in psychogenic non-epileptic seizures (PNES), and none of long-term healthcare utilization.
METHODS: We studied attendance with seizures, healthcare use and employment over a 6-month period from the family doctors of 260 consecutive patients with psychogenic non-epileptic seizures (PNES), 5-10 years after diagnosis.
RESULTS: We obtained clinical data in 188/260 patients (72.3%), of whom 60 (31.9%) had attended primary or secondary care with seizures in the previous 6 months. Predictors of attendance with seizures included a diagnosis of epilepsy+PNES (OR 5.7, p=0.009), work status (OR 3.9, p=0.027) and social security payments (OR 6.3, p=0.003). Latency to diagnosis was not predictive. Emergency admission data were available in 187 patients, of whom 25 (13.4%) had emergency hospital attendances. Prescription data were available for 172 patients, of whom 154 had 'PNES only'. Of these, 17 (11.0%) remained on antiepileptic medication (AED). 68/172 patients (39.5%) were prescribed antidepressant (AD) drugs. We had psychiatric contact data in 185 patients, of whom 49 (26.5%) had accessed psychiatric services in the last 6 months.
CONCLUSIONS: Surprisingly few of our patients had presented with seizures during the study period. Early reductions in both AED use and healthcare use were sustained long term. Although psychiatric and employment outcomes were less encouraging, some aspects of PNES outcome may be better than previously thought. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  ANTICONVULSANTS; BEHAVIOURAL DISORDER; NEUROPSYCHIATRY; NEUROPSYCHOLOGY; SOMATISATION DISORDER

Mesh:

Substances:

Year:  2014        PMID: 24444852     DOI: 10.1136/jnnp-2013-306671

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  7 in total

1.  Issues in PNES Treatment.

Authors:  Barbara A Dworetzky
Journal:  Epilepsy Curr       Date:  2015 Mar-Apr       Impact factor: 7.500

2.  Long-Term Outcomes in Psychogenic Syncope: A Fallout for Neurologists.

Authors:  Barbara A Dworetzky
Journal:  Epilepsy Curr       Date:  2017 May-Jun       Impact factor: 7.500

3.  The Impact of PNES is About More than Counting Events.

Authors:  Barbara Dworetzky
Journal:  Epilepsy Curr       Date:  2016 Sep-Oct       Impact factor: 7.500

Review 4.  Treatment of psychogenic nonepileptic seizures: updated review and findings from a mindfulness-based intervention case series.

Authors:  Gaston Baslet; Barbara Dworetzky; David L Perez; Megan Oser
Journal:  Clin EEG Neurosci       Date:  2014-12-02       Impact factor: 1.843

Review 5.  Treatment of Psychogenic Nonepileptic Seizures.

Authors:  M Raquel Lopez; W Curt LaFrance
Journal:  Curr Neurol Neurosci Rep       Date:  2022-06-08       Impact factor: 6.030

6.  Functional Neurologic Disorders: The Need for a Model of Care.

Authors:  Mary A O'Neal; Gaston C Baslet; Ginger R Polich; Geoffrey S Raynor; Barbara A Dworetzky
Journal:  Neurol Clin Pract       Date:  2021-04

7.  PNES around the world: Where we are now and how we can close the diagnosis and treatment gaps-an ILAE PNES Task Force report.

Authors:  Kousuke Kanemoto; W Curt LaFrance; Roderick Duncan; David Gigineishvili; Sung-Pa Park; Yukari Tadokoro; Hiroko Ikeda; Ravi Paul; Dong Zhou; Go Taniguchi; Mike Kerr; Tomohiro Oshima; Kazutaka Jin; Markus Reuber
Journal:  Epilepsia Open       Date:  2017-06-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.